Add this result to my export selection EUnetHTA Joint Action 3 WP4: Biodegradable rectum spacers to reduce toxicity for prostate cancer (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 28 July 2020 The Other Technologies Collaborative Assessment OTCA23 final assessment report “Biodegradable rectum spacers to reduce toxicity for prostate cancer”, together with related documentation, is now... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 22 June 2020 EUnetHTA is pleased to announce that the “Rapid Collaborative Review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic” is now available. ... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: Point-of-care Tests (POCT): D-Dimer and Troponin (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 12 December 2019 Troponin and D-dimer point of care tests can be used to aid the diagnosis of patients with symptoms suggestive of suspected acute coronary syndrome and venous thromboembolism respectively. This... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: Regional hyperthermia for high-risk soft tissue sarcoma treatment (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 28 October 2019 The final assessment report and related documents concerning OTCA18, ‘regional hyperthermia for high-risk soft tissue sarcoma treatment’, are now available. The assessed technology is regional... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response with, lost response to or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 22 October 2019 This is the pharmaceutical Joint Assessment PTJA07 – on ustekinumab for the treatment of ulcerative colitis (UC). In September 2019, EMA approved the extension of the indication for ustekinumab to... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: Stool DNA testing for early detection of colorectal cancer (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 29 July 2019 The health technology assessed is a non-invasive device for the early detection of colorectal cancer that supplements the established fecal occult blood tests with the stool-based analysis of tumor... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection EUnetHTA Joint Action 3 WP4: C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs) (PDF) Source: EUnetHTA (Remove filter) Published by EUnetHTA, 31 January 2019 We are pleased to announce that the collaborative rapid assessment on “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection Cognitive behavioural therapy-based intervention to reduce fear of falling in older people: therapy development and randomised controlled trial the Strategies for Increasing Independence, Confidence and Energy (STRIDE) study Source: NIHR Journals Library - Health Technology Assessment (Remove filter) Published by NIHR Journals Library – Health Technology Assessment, 01 August 2016 (2016) Cognitive behavioural therapy-based intervention to reduce fear of falling in older people: therapy development and randomised controlled trial the Strategies for Increasing Independence, ... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection The feasibility of determining the effectiveness and cost-effectiveness of medication organisation devices compared with usual care for older people in a community setting: systematic review, stakeholder focus groups and feasibility randomised controlled trial Source: NIHR Journals Library - Health Technology Assessment (Remove filter) Published by NIHR Journals Library – Health Technology Assessment, 01 July 2016 (2016) The feasibility of determining the effectiveness and cost-effectiveness of medication organisation devices compared with usual care for older people in a community setting: systematic review, ... Read Summary Type: Health Technology Assessments (Remove filter)
Add this result to my export selection A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial Source: NIHR Journals Library - Health Technology Assessment (Remove filter) Published by NIHR Journals Library – Health Technology Assessment, 01 October 2015 (2015) A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for... Read Summary Type: Health Technology Assessments (Remove filter)